Patents by Inventor Frederic Marc

Frederic Marc has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10526663
    Abstract: The present invention relates to a method of detecting a microorganism, in particular Staphylococcus aureus, in a sample, comprising the steps of a) incubating the sample with a slow off-rate modified aptamer (SOMAmer) comprising a fluorescent label, b) optionally washing the sample, c) analyzing the sample by a fluorescence-based detection method. The invention further relates to a slow off-rate modified aptamer comprising a fluorescent label, wherein the SOMAmer comprises a nucleotide sequence specific for Staphylococcus aureus, its use for detecting Staphylococcus aureus cells in a sample, and to a microarray or biosensor and a kit comprising at least one of such SOMAmers comprising a fluorescent label.
    Type: Grant
    Filed: February 20, 2015
    Date of Patent: January 7, 2020
    Assignees: Merck Patent GmbH, SOMALOGIC, Inc.
    Inventors: Anne Baumstummler, Frederic Marc-Kreucher, David Lehmann, Urs Ochsner, Nebojsa Janjic
  • Patent number: 10280180
    Abstract: This invention relates macrocyclic purine derivatives, processes for their preparation, pharmaceutical compositions, and their use in treating viral infections.
    Type: Grant
    Filed: July 12, 2013
    Date of Patent: May 7, 2019
    Assignee: Janssen Sciences Ireland UC
    Inventors: Jean-Francois Bonfanti, Jerome Michel Claude Fortin, Philippe Muller, Frederic Marc Maurice Doublet, Pierre Jean-Marie Bernard Raboisson, Eric Pierre Alexandre Arnoult
  • Patent number: 10221157
    Abstract: The present invention relates to novel compounds of formula I: or a pharmaceutically acceptable salt thereof, wherein the integers are as defined in the description. The claimed compounds are useful for the treatment of a bacterial infection. Also claimed is a composition comprising a pharmaceutically acceptable carrier and, as active ingredient, a therapeutically effective amount of the claimed compounds, the use of the claimed compounds or compositions for the manufacture of a medicament for the treatment of a bacterial infection and a process for preparing the claimed compounds.
    Type: Grant
    Filed: August 4, 2017
    Date of Patent: March 5, 2019
    Assignee: Janssen Pharmaceutica NV
    Inventors: Jean-Francois Bonfanti, Philippe Muller, Frederic Marc Maurice Doublet, Jerome Michel Claude Fortin, Nacer Lounis
  • Publication number: 20170334880
    Abstract: The present invention relates to novel compounds of formula I: or a pharmaceutically acceptable salt thereof, wherein the integers are as defined in the description. The claimed compounds are useful for the treatment of a bacterial infection. Also claimed is a composition comprising a pharmaceutically acceptable carrier and, as active ingredient, a therapeutically effective amount of the claimed compounds, the use of the claimed compounds or compositions for the manufacture of a medicament for the treatment of a bacterial infection and a process for preparing the claimed compounds.
    Type: Application
    Filed: August 4, 2017
    Publication date: November 23, 2017
    Inventors: Jean-Francois BONFANTI, Philippe MULLER, Frederic Marc Maurice DOUBLET, Jerome Michel Claude FORTIN, Nacer LOUNIS
  • Patent number: 9725432
    Abstract: The present invention relates to novel compounds of formula I: or a pharmaceutically acceptable salt thereof, wherein the integers are as defined in the description. The claimed compounds are useful for the treatment of a bacterial infection. Also claimed is a composition comprising a pharmaceutically acceptable carrier and, as active ingredient, a therapeutically effective amount of the claimed compounds, the use of the claimed compounds or compositions for the manufacture of a medicament for the treatment of a bacterial infection and a process for preparing the claimed compounds.
    Type: Grant
    Filed: April 30, 2013
    Date of Patent: August 8, 2017
    Assignee: Janssen Sciences Ireland US
    Inventors: Jean-Francois Bonfanti, Philippe Muller, Frederic Marc Maurice Doublet, Jerome Michel Claude Fortin, Nacer Lounis
  • Publication number: 20170051337
    Abstract: The present invention relates to a method of detecting a microorganism, in particular Staphylococcus aureus, in a sample, comprising the steps of a) incubating the sample with a slow off-rate modified aptamer (SOMAmer) comprising a fluorescent label, b) optionally washing the sample, c) analyzing the sample by a fluorescence-based detection method. The invention further relates to a slow off-rate modified aptamer comprising a fluorescent label, wherein the SOMAmer comprises a nucleotide sequence specific for Staphylococcus aureus, its use for detecting Staphylococcus aureus cells in a sample, and to a microarray or biosensor and a kit comprising at least one of such SOMAmers comprising a fluorescent label.
    Type: Application
    Filed: February 20, 2015
    Publication date: February 23, 2017
    Applicants: Merck Patent GmbH, SOMALOGIC, Inc.
    Inventors: Anne BAUMSTUMMLER, Frederic MARC-KREUCHER, David LEHMANN, Urs OCHSNER, Nebojsa JANJIC
  • Publication number: 20160304531
    Abstract: This invention relates to macrocyclic deaza-purinones derivatives, processes for their preparation, pharmaceutical compositions, and their use in treating viral infections.
    Type: Application
    Filed: March 28, 2014
    Publication date: October 20, 2016
    Inventors: Jean-Francois Bonfanti, Jerome Michel Claude Fortin, Philippe Muller, Frederic Marc Maurice Doublet, Pierre Jean-Marie Bernard Raboisson, Eric Pierre Alexandre Arnoult
  • Publication number: 20150299221
    Abstract: This invention relates macrocyclic purine derivatives, processes for their preparation, pharmaceutical compositions, and their use in treating viral infections.
    Type: Application
    Filed: July 12, 2013
    Publication date: October 22, 2015
    Inventors: Jean-Francois Bonfanti, Jerome Michel Claude Fortin, Philippe Muller, Frederic Marc Maurice Doublet, Pierre Jean-Marie Bernard Raboisson, Eric Pierre Alexandre Arnoult
  • Patent number: 9080198
    Abstract: The invention relates to a growth medium allying a fluorogenic substrate and a pH-sensitive fluorophore, in particular the combination of 4-methylumbelliferone (4-MU) and derivatives of fluorescein. This growth medium is used for the detection by fluorescence of microorganisms by coupling the fluorescence measurements relating to the pH-sensitive fluorophor and the fluorescence measurements relating to the activation of the fluorogenic substrate(s) by the microorganisms.
    Type: Grant
    Filed: January 19, 2011
    Date of Patent: July 14, 2015
    Assignee: EMD Millipore Corporation
    Inventor: Frederic Marc
  • Patent number: 9034281
    Abstract: A device (1, 100) for separating a membrane (81, 91) to analyze from a support (83, 93), the membrane being mounted in a frame (82, 92), itself mounted on a support, having a body (10) comprising a longitudinal recess (11, 110, 120) for translational reception of the assembly constituted by the frame mounted on the support, the recess having a first end (12) and a second end (13) and longitudinal sides (14A, 14B, 111, 121) facing each other between said two ends, the device having bearing means (30, 112, 122) for a first member of the frame/support group between the first and the second end of the recess, which are adapted to serve as a bearing for the first member of the frame/support group once the assembly is disposed in the recess, each of the sides having a ramp (15A, 15B, 112, 122) adapted to engage a gripping member (84, 73) of the second member of the frame/support group when the assembly is translationally moved from the first to the second end, said ramps being adapted to separate the support from t
    Type: Grant
    Filed: February 2, 2011
    Date of Patent: May 19, 2015
    Assignee: EMD Millipore Corporation
    Inventors: Frederic Marc, Luc Felden, Gael Waiche, Jean-Jacques Richert
  • Publication number: 20150087651
    Abstract: The present invention relates to novel compounds of formula I: or a pharmaceutically acceptable salt thereof, wherein the integers are as defined in the description. The claimed compounds are useful for the treatment of a bacterial infection. Also claimed is a composition comprising a pharmaceutically acceptable carrier and, as active ingredient, a therapeutically effective amount of the claimed compounds, the use of the claimed compounds or compositions for the manufacture of a medicament for the treatment of a bacterial infection and a process for preparing the claimed compounds.
    Type: Application
    Filed: April 30, 2013
    Publication date: March 26, 2015
    Inventors: Jean-Francois Bonfanti, Philippe Muller, Frederic Marc Maurice Doubler, Jerome Michel Claude Fortin, Nacer Lounis
  • Patent number: 8504816
    Abstract: Various embodiments include an integrated circuit (IC) device having a conductive contact, and a circuit to determine a resistance value of a circuit path between the conductive contact and a circuit node during an initialization mode of the device. The IC device includes a controller to select at least one value of at least one operating parameter of the device based at least in part on the resistance value.
    Type: Grant
    Filed: January 12, 2010
    Date of Patent: August 6, 2013
    Assignee: Atmel Rousset S.A.S.
    Inventors: Frederic Marc Edouard Claudet, Bruno Pierre Lucien Poncet
  • Publication number: 20120315663
    Abstract: A device (1, 100) for separating a membrane (81, 91) to analyze from a support (83, 93), the membrane being mounted in a frame (82, 92), itself mounted on a support, having a body (10) comprising a longitudinal recess (11, 110, 120) for translational reception of the assembly constituted by the frame mounted on the support, the recess having a first end (12) and a second end (13)and longitudinal sides(14A, 14B, 111, 121) facing each other between said two ends, the device having bearing means (30, 112, 122) for a first member of the frame/support group between the first and the second end of the recess, which are adapted to serve as a bearing for the first member of the frame/support group once the assembly is disposed in the recess, each of the sides having a ramp (15A, 15B, 112, 122) adapted to engage a gripping member (84, 73) of the second member of the frame/support group when the assembly is translationally moved from the first to the second end, said ramps being adapted to separate the support from the
    Type: Application
    Filed: February 2, 2011
    Publication date: December 13, 2012
    Applicant: EMD Millipore Corporation
    Inventors: Frederic Marc, Luc Felden, Gael Waiche, Jean-Jacques Richert
  • Publication number: 20120301916
    Abstract: The invention relates to a growth medium allying a fluorogenic substrate and a pH-sensitive fluorophore, in particular the combination of 4-methylumbelliferone (4-MU) and derivatives of fluorescein. This growth medium is used for the detection by fluorescence of microorganisms by coupling the fluorescence measurements relating to the pH-sensitive fluorophor and the fluorescence measurements relating to the activation of the fluorogenic substrate(s) by the microorganisms.
    Type: Application
    Filed: January 19, 2011
    Publication date: November 29, 2012
    Applicant: EMD MILLIPORE CORPORATION
    Inventor: Frederic Marc
  • Patent number: 8148081
    Abstract: The present invention relates to a method using a composition for permeabilizing microorganism walls for counting and detecting in a targeted manner the microorganisms on a membrane. The invention also relates to a kit and to probes that are suitable for carrying out the method.
    Type: Grant
    Filed: January 25, 2010
    Date of Patent: April 3, 2012
    Assignee: EMD Millipore Corporation
    Inventors: Sebastien Ribault, Frederic Marc
  • Publication number: 20110318744
    Abstract: The present invention relates to a method for the specific detection on a filter of one or more microorganisms present in a fluid, characterized in that it comprises the following steps: a) contacting the microorganisms present in the fluid or on the surface with the filter; b) amplifying specifically the nucleic acids from the microorganism or microorganisms present on the filter, in an isothermal manner, in order to obtain amplification products, c) detecting the amplification products. The invention also relates to a device, a kit and oligonucleotides suitable for the implementation of this method.
    Type: Application
    Filed: August 1, 2011
    Publication date: December 29, 2011
    Applicant: MILLIPORE CORPORATION
    Inventors: Frederic Marc, Serge Ohresser
  • Publication number: 20110245352
    Abstract: The present invention relates to a composition for permeabilizing the walls of microorganisms, comprising the combination of polyethyleneimine (PEI) and ethylenediaminetetraacetic acid (EDTA), and to a method using said composition for counting and detecting, in a targeted manner, the microorganisms on a membrane. The invention also relates to a kit comprising probes suitable for implementing said method.
    Type: Application
    Filed: September 2, 2010
    Publication date: October 6, 2011
    Applicant: Millipore Corporation
    Inventors: Frederic Marc, Marisa Hohnadel
  • Publication number: 20110173424
    Abstract: Various embodiments include an integrated circuit (IC) device having a conductive contact, and a circuit to determine a resistance value of a circuit path between the conductive contact and a circuit node during an initialization mode of the device. The IC device includes a controller to select at least one value of at least one operating parameter of the device based at least in part on the resistance value.
    Type: Application
    Filed: January 12, 2010
    Publication date: July 14, 2011
    Applicant: Atmel Rousset
    Inventors: Frederic Marc Edouard Claudet, Bruno Pierre Lucien Poncet
  • Publication number: 20110065110
    Abstract: The invention relates to a method for the extraction and detection of nucleic acids on a membrane, making it possible to identify the microorganisms present in low concentration in a liquid or gaseous medium, as well as a novel lysis composition comprising guanidium chloride and between 0.1 and 1% N-Lauroyl-Sarcosine (NLS) making it possible to implement this method.
    Type: Application
    Filed: August 3, 2010
    Publication date: March 17, 2011
    Applicant: MILLIPORE CORPORATION
    Inventors: Roxana Isac, Frederic Marc
  • Publication number: 20110059433
    Abstract: The present invention relates to a method for the specific detection on a filter of one or more microorganisms present in a fluid, characterized in that it comprises the following steps: a) contacting the microorganisms present in the fluid or on the surface with the filter; b) amplifying specifically the nucleic acids from the microorganism or microorganisms present on the filter, in an isothermal manner, in order to obtain amplification products, c) detecting the amplification products. The invention also relates to a device, a kit and oligonucleotides suitable for the implementation of this method.
    Type: Application
    Filed: April 26, 2006
    Publication date: March 10, 2011
    Inventors: Frederic Marc, Serge Ohresser